TYRA$21.240.63%-0.135
Tyra Biosciences Inc (TYRA)
Date: 2026-11-04 16:00O: 21.91H: 21.91L: 20.78C: 21.30Vol: 288.7k
Tyra Biosciences Inc stock is traded at $21.24, with a volume of 197,447. It is down -0.63% in the last 24 hours and up +3.94% over the past month. Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Previous Close:
$21.37
Open:
$21.91
24h Volume:
197,447
Relative Volume:
0.33
Market Cap:
$1.46B
Revenue:
-
Net Income/Loss:
-$131.11M
P/E Ratio:
-
EPS:
-$2.17
Net Cash Flow:
-$102.47M
1W Performance:
-2.37%
1M Performance:
+3.94%
6M Performance:
-39.57%
1Y Performance:
+41.57%
1-Day Range:
$20.78$21.91
1-Week Range:
$20.32$22.37
52-Week Range:
$13.35$40.65
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences IncSector
HealthcareIndustry
BiotechnologyPhone
(619) 728-4760Address
2656 STATE STREET, CARLSBAD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
Tyra Biosciences Inc Stock (TYRA) Financials Data
Tyra Biosciences Inc Stock (TYRA) Insider Trading
- Verjee RehanSep 09 '26Director
- Transaction
- Buy
- Cost
- $20.58
- #Shares
- 972
- Value ($)
- 20,000
- #Shares Total
- 972
- NEXTECH VI ONCOLOGY SCSPJun 26 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $30.94
- #Shares
- 308,379
- Value ($)
- 9,541,246
- #Shares Total
- 0
- NEXTECH VI ONCOLOGY SCSPJun 01 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $33.41
- #Shares
- 300,000
- Value ($)
- 10,023,000
- #Shares Total
- 0
- Daniel BensenMay 12 '26Officer
- Transaction
- Proposed Sale
- Cost
- $34.25
- #Shares
- 8,000
- Value ($)
- 274,000
- #Shares Total
- 0
- Daniel BensenApr 13 '26Officer
- Transaction
- Proposed Sale
- Cost
- $35.62
- #Shares
- 8,000
- Value ($)
- 285,000
- #Shares Total
- 0
- GILLA KAPLANMar 26 '26Director
- Transaction
- Proposed Sale
- Cost
- $37.75
- #Shares
- 53,172
- Value ($)
- 2,007,153
- #Shares Total
- 0
- GILLA KAPLANMar 25 '26Director
- Transaction
- Proposed Sale
- Cost
- $36.97
- #Shares
- 14,295
- Value ($)
- 528,506
- #Shares Total
- 0
- KAPLAN GILLAMar 25 '26Director
- Transaction
- Option Exercise
- Cost
- $2.25
- #Shares
- 14,295
- Value ($)
- 32,164
- #Shares Total
- 42,526
- KAPLAN GILLAMar 25 '26Director
- Transaction
- Sale
- Cost
- $36.97
- #Shares
- 14,295
- Value ($)
- 528,506
- #Shares Total
- 28,231
- Daniel BensenMar 12 '26Officer
- Transaction
- Proposed Sale
- Cost
- $35.38
- #Shares
- 8,000
- Value ($)
- 283,000
- #Shares Total
- 0
